Yu A Belova Selected Research

Relapsing-Remitting Multiple Sclerosis

1/2016

[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu A Belova Research Topics

Disease

3	Multiple Sclerosis 01/2023 - 01/2016
3	Ischemic Stroke 01/2018 - 01/2016
1	Epilepsy (Aura) 01/2019
1	Embolic Stroke 01/2018
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2018
1	Aphasia (Dysphasia) 01/2017
1	Pain (Aches) 01/2017
1	Paresthesia (Dysesthesia) 01/2017
1	Polyneuropathies (Polyneuropathy) 01/2017
1	Mononeuropathies (Mononeuritis Multiplex) 01/2017
1	Neuralgia (Stump Neuralgia) 01/2017
1	Hyperglycemia 01/2016
1	Relapsing-Remitting Multiple Sclerosis 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Partial Epilepsies (Epilepsy, Partial) 01/2015

Drug/Important Bio-Agent (IBA)

2	Natalizumab (Tysabri)FDA Link 01/2023 - 01/2019
2	Zonisamide (Zonegran)FDA LinkGeneric 01/2019 - 01/2015
2	Vitamin B Complex (B Vitamins)IBA 01/2018 - 01/2017
1	Monoclonal AntibodiesIBA 01/2023
1	ocrelizumabIBA 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2018
1	1- ((2- (5- dimethylamino)naphthalene- 1- sulfonylaminoethyl)amino)- 3- (1- naphthaleneoxy)- 2- propanolIBA 01/2017
1	Pregabalin (Lyrica)FDA Link 01/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2017
1	Glatiramer Acetate (Copaxone)FDA Link 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2015

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2016
2	Thrombolytic Therapy 01/2018 - 01/2016
1	Immunomodulation 01/2019
1	Injections 01/2017